Review article: delivering precision oncology in intermediate-stage liver cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Review article: delivering precision oncology in intermediate-stage liver cancer

Published:2017-04-25 Issue:12 Volume:45 Page:1514-1523
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Pinato D. J.¹^ORCID,Howell J.¹²³⁴^ORCID,Ramaswami R.¹,Sharma R.¹

Affiliation:

1. Division of Surgery and Cancer; Hammersmith Campus of Imperial College London; London UK

2. Centre for Population Health; MacFarlane-Burnet Institute; Melbourne VIC Australia

3. Department of Medicine; Royal Melbourne Hospital and St Vincent's Hospital; Melbourne VIC Australia

4. University of Melbourne; Melbourne VIC Australia

Funder

National Institute for Health Research

Academy of Medical Sciences

Imperial NIHR Biomedical Research Centre (BRC)

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.14066/fullpdf

Reference74 articles.

1. Management of hepatocellular carcinoma;Bruix;Hepatology,2005

2. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma;European Association for Study of L, European Organisation for R, Treatment of C.;Eur J Cancer,2012

3. A meta-analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma;Cabibbo;Hepatology,2010

4. Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using drug eluting beads. Implications for clinical practice and trial design;Burrel;J Hepatol,2012

5. Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: available evidence and expert opinion on the use of transarterial chemoembolization;Raoul;Cancer Treat Rev,2011

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Prognostic Model To Predict Survival After Recurrence Among Patients With Recurrent Hepatocellular Carcinoma;Annals of Surgery;2023-07-31

2. Intermediate-stage (BCLC stage B) infiltrative hepatocellular carcinoma: safety and efficacy of chemoembolization;European Radiology;2023-07-19

3. PETAL protocol: a phase Ib study of pembrolizumab after transarterial chemoembolization in hepatocellular carcinoma;Future Oncology;2023-03

4. Development and Validation of an α-Fetoprotein Tumor Burden Score Model to Predict Postrecurrence Survival among Patients with Hepatocellular Carcinoma;Journal of the American College of Surgeons;2023-02-06

5. Continuous care needs in patients with cancer receiving chemotherapy during the recent omicron wave of COVID-19 in Shanghai: A qualitative study;Frontiers in Psychology;2023-01-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3